Syneos Health, Inc. Overview
Pro stress-test →Syneos Health is a biopharmaceutical solutions company that utilizes outsourced clinical drug development and commercialization services, operating through Clinical Solutions and Commercial Solutions segments. The company serves small, mid-sized, and large companies in the biopharmaceutical and biotechnology sectors across North America, Europe, and Asia-Pacific.
Strategic Profile
Pro stress-test →The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, and devices spanning Phase I to IV clinical development, while the Commercial Solutions segment provides commercialization, communications, and consulting services. The company is a leading integrated contract research and commercialization services provider, positioned as a strategic partner in the drug development lifecycle.
Competitive Landscape
Pro stress-test →Syneos Health competes with integrated contract research and commercialization service providers including Charles River Laboratories, IQVIA, and Parexel. The company differentiates through its dual Clinical and Commercial Solutions platforms, serving the full drug development and launch cycle. However, competitive intensity and pricing pressure from larger, diversified providers present ongoing challenges.
Industry Context
Syneos Health, Inc. operates in Contract Research Organization (CRO) / Biopharmaceutical Outsourcing Services.
Key facts
Founded: 2010 · Headquarters: Morrisville, North Carolina · Employees: 26,751 · Revenue: $5.41B · Market cap: $4.46B